Prof Faisal Sharif is Professor in Translational Cardiovascular Medicine and Innovation at NUI, Galway and a consultant Interventional Cardiologist for Galway University Hospitals. His research focuses on medical devices for cardiovascular medicine and translational research on vascular biology and myocardial regeneration.

Prof Sharif’s has established strong industrial–clinical partnership with incorporation of novel medical devices including optical coherence tomography, renal artery denervation and transcatheter aortic valve implantation. He was the Principal Investigator for multinational randomised clinical trial involving autologous stem cell injection in patients with heart failure. Prof Sharif also continues to pursue research on vascular wall healing post-stenting through development of novel techniques and devices. His research focuses on developing novel solutions for unmet clinical needs for cardiovascular medicine. Prof Sharif’s key area of interest is translational medicine focusing on cardiovascular clinical trials for medical devices and basic science outputs. Prof Sharif has been inducted as a Fellow to the Royal College of Physicians Ireland (FRCPI), the European Society of Cardiology (FESC), the American College of Cardiology (FACC). He is the Associate Director for Clinical Research facility Galway for cardiovascular trials.

Prof Sharif has authored over 20 peer-reviewed articles, filed three invention disclosures and holds two patents. He has also coordinated two clinical trials.

Prof Sharif is Clinical Director and Advisory Board member for BioInnovate Ireland. He is also serves as a board and faculty member for the Resistant Hypertension Course hosted by EuroPCR, the First Centre of Excellence (CoE) for renal artery denervation training in United Kingdom and Ireland.